|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.600 SEK | -3.49% |
|
-4.00% | +144.90% |
| 07-23 | Sprint Bioscience AB and Eli Lilly and Company Enter Agreement to Accelerate Drug Development | CI |
| 06-26 | Four stocks have so far today posted new 52-week highs on the Stockholm Stock Exchange | FW |
| Market Cap | 380M 39.95M 34.63M 32.24M 29.62M 55.99M 3.81B 56.87M 149M 1.9B 150M 147M 6.34B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 380M 39.95M 34.63M 32.24M 29.62M 55.99M 3.81B 56.87M 149M 1.9B 150M 147M 6.34B | EV / Sales 2026 * |
4.48x | EV / Sales 2027 * | 2.45x |
| Free-Float |
64.78% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -3.49% | ||
| 1 week | -4.00% | ||
| Current month | -13.04% | ||
| 1 month | -13.04% | ||
| 3 months | +15.76% | ||
| 6 months | +121.54% | ||
| Current year | +144.90% |
| 1 week | 3.52 |  | 3.8 |
| 1 month | 3.5 | | 4.39 |
| Current year | 1.36 | | 4.59 |
| 1 year | 0.51 | | 4.59 |
| 3 years | 0.36 | | 4.59 |
| 5 years | 0.36 | | 9.36 |
| 10 years | 0.36 | | 41.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Johan Emilsson
CEO | Chief Executive Officer | 42 | 01/10/2023 |
Martin Andersson
CTO | Chief Tech/Sci/R&D Officer | 55 | 01/01/2009 |
| Director of Finance/CFO | 55 | 04/05/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 70 | 01/01/2010 | |
Fredrik Lehmann
BRD | Director/Board Member | 50 | 01/01/2019 |
| Chairman | 58 | 01/01/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.49% | -4.00% | +510.17% | +640.74% | 41.22M | |
| +2.35% | +0.77% | +29.92% | +85.38% | 55.23B | |
| -0.21% | -6.52% | +42.39% | +64.10% | 53.75B | |
| -2.44% | -1.61% | -17.69% | -15.68% | 23.48B | |
| -2.85% | -8.20% | -6.26% | +361.83% | 22B | |
| +2.49% | -1.27% | +15.99% | -10.53% | 19.78B | |
| +0.79% | -2.39% | +26.99% | -31.34% | 17.44B | |
| +0.58% | -7.23% | +24.50% | +519.07% | 14.66B | |
| -5.25% | -4.71% | +43.89% | +167.15% | 14.07B | |
| +3.41% | -7.83% | +161.76% | +284.91% | 13.02B | |
| Average | -0.46% | -0.90% | +83.17% | +206.56% | 23.35B | |
| Weighted average by Cap. | +0.17% | +0.09% | +31.13% | +122.90% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 84.8M 8.92M 7.73M 7.2M 6.61M 12.5M 851M 12.7M 33.31M 423M 33.49M 32.75M 1.41B | 155M 16.3M 14.13M 13.15M 12.08M 22.85M 1.55B 23.21M 60.88M 774M 61.21M 59.87M 2.59B |
| Net income | - | - |
| Net Debt | - | - |
Employees
30
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/07/26 | SEK 3.600 | -3.49% | 243,702 |
| 30/07/26 | SEK 3.730 | +0.27% | 400,504 |
| 29/07/26 | SEK 3.720 | -.--% | 94,705 |
| 28/07/26 | SEK 3.720 | -.--% | 107,786 |
| 27/07/26 | SEK 3.720 | +1.64% | 93,270 |
Net sales - Rate of surprise
- Stock Market
- Stocks
- SPRINT Stock
Select your edition
All financial news and data tailored to specific country editions
